{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:00:17Z","timestamp":1791140417517,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,30]],"date-time":"2011-07-30T00:00:00Z","timestamp":1311984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00401-011-0861-8","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T07:33:14Z","timestamp":1311924794000},"source":"Crossref","is-referenced-by-count":162,"title":["Factors affecting A\u03b2 plasma levels and their utility as biomarkers in ADNI"],"prefix":"10.1007","volume":"122","author":[{"given":"Jon B.","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Vanderstichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Figurski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Decarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur W.","family":"Toga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon X.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.-Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,30]]},"reference":[{"key":"861_CR1","doi-asserted-by":"crossref","unstructured":"(1998) Consensus report of the Working Group on: \u201cMolecular and Biochemical Markers of Alzheimer\u2019s Disease\u201d. The Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association and the National Institute on Aging Working Group. Neurobiology of aging 19(2): 109\u2013116","DOI":"10.1016\/S0197-4580(98)00022-0"},{"issue":"2","key":"861_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/ajp.154.2.165","volume":"154","author":"G Alexander","year":"1997","unstructured":"Alexander G, Furey M, Grady C et al (1997) Association of premorbid intellectual function with cerebral metabolism in Alzheimer\u2019s disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 154(2):165\u2013172","journal-title":"Am J Psychiatry"},{"issue":"3","key":"861_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00002093-200207000-00009","volume":"16","author":"Z Arvanitakis","year":"2002","unstructured":"Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR (2002) Serum creatinine levels correlate with plasma amyloid [beta] protein. Alzheimer Dis Assoc Disord 16(3):187\u2013190","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8","key":"861_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.neurobiolaging.2005.03.006","volume":"26","author":"I Blasko","year":"2005","unstructured":"Blasko I, Kemmler G, Krampla W et al (2005) Plasma amyloid [beta] protein 42 in non-demented persons aged 75\u00a0years: effects of concomitant medication and medial temporal lobe atrophy. Neurobiol Aging 26(8):1135\u20131143","journal-title":"Neurobiol Aging"},{"issue":"3","key":"861_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12603-009-0059-0","volume":"13","author":"K Blennow","year":"2009","unstructured":"Blennow K, De Meyer G, Hansson O et al (2009) Evolution of Abeta42 and Abeta40 levels and Abeta42\/Abeta40 ratio in plasma during progression of Alzheimer\u2019s disease: a multicenter assessment. J Nutr Health Aging 13(3):205\u2013208","journal-title":"J Nutr Health Aging"},{"issue":"5","key":"861_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/01688638708410764","volume":"9","author":"N Butters","year":"1987","unstructured":"Butters N, Granholm E, Salmon D, Grant I, Wolfe J (1987) Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol 9(5):479\u2013497","journal-title":"J Clin Exp Neuropsychol"},{"issue":"11","key":"861_CR7","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1001\/archneurol.2010.284","volume":"67","author":"O Carmichael","year":"2010","unstructured":"Carmichael O, Schwarz C, Drucker D et al (2010) Longitudinal changes in white matter disease and cognition in the first year of the alzheimer disease neuroimaging initiative. Arch Neurol 67(11):1370\u20131378","journal-title":"Arch Neurol"},{"issue":"12","key":"861_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/archneurol.2010.189","volume":"67","author":"SA Cosentino","year":"2010","unstructured":"Cosentino SA, Stern Y, Sokolov E et al (2010) Plasma {beta}-amyloid and cognitive decline. Arch Neurol 67(12):1485\u20131490","journal-title":"Arch Neurol"},{"issue":"1","key":"861_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","volume":"213","author":"M Chen","year":"1995","unstructured":"Chen M, Inestrosa NC, Ross GS, Fernandez HL (1995) Platelets are the primary source of amyloid [beta]-peptide in human blood. Biochem Biophys Res Commun 213(1):96\u2013103","journal-title":"Biochem Biophys Res Commun"},{"key":"861_CR10","unstructured":"Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN and Trojanowski JQ (2010) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol aging"},{"issue":"3","key":"861_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","volume":"82","author":"LC Souza de","year":"2011","unstructured":"de Souza LC, Lamari F, Belliard S et al (2011) Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer\u2019s disease from other cortical dementias. J Neurol Neurosurg Psychiatry 82(3):240\u2013246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"861_CR12","doi-asserted-by":"crossref","unstructured":"Devanand DP, Schupf N, Stern Y et al (2011) Plasma A\u03b2 and PET PiB binding are inversely related in mild cognitive impairment. Neurology","DOI":"10.1212\/WNL.0b013e318224afb7"},{"issue":"8\u20139","key":"861_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/emmm.200900048","volume":"1","author":"AM Fagan","year":"2009","unstructured":"Fagan AM, Mintun MA, Shah AR et al (2009) Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer\u2019s disease. EMBO Mol Med 1(8\u20139):371\u2013380","journal-title":"EMBO Mol Med"},{"key":"861_CR14","doi-asserted-by":"crossref","unstructured":"Fagan AM, Shaw LM, Xiong C et al (2011) Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of {beta}-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology. Arch Neurol","DOI":"10.1001\/archneurol.2011.105"},{"issue":"1\u20132","key":"861_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jns.2011.03.005","volume":"305","author":"M Fei","year":"2011","unstructured":"Fei M, Jianghua W, Rujuan M, Wei Z, Qian W (2011) The relationship of plasma A[beta] levels to dementia in aging individuals with mild cognitive impairment. J Neurol Sci 305(1\u20132):92\u201396","journal-title":"J Neurol Sci"},{"issue":"3","key":"861_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198","journal-title":"J Psychiatr Res"},{"issue":"7","key":"861_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/archneur.60.7.958","volume":"60","author":"H Fukumoto","year":"2003","unstructured":"Fukumoto H, Tennis M, Locascio JJ et al (2003) Age but not diagnosis is the main predictor of plasma amyloid {beta}-protein levels. Arch Neurol 60(7):958\u2013964","journal-title":"Arch Neurol"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2307\/1270037","volume":"34","author":"KM Goldberg","year":"1992","unstructured":"Goldberg KM, Iglewicz B (1992) Bivariate extensions of the boxplot. Technometrics 34:307\u2013320","journal-title":"Technometrics"},{"key":"861_CR19","volume-title":"The assessment of aphasia and related disorders","author":"H Goodglass","year":"1983","unstructured":"Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders. Lea & Febiger, Philadelphia"},{"issue":"3","key":"861_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/archneur.64.3.354","volume":"64","author":"NR Graff-Radford","year":"2007","unstructured":"Graff-Radford NR, Crook JE, Lucas J et al (2007) Association of low plasma Abeta42\/Abeta40 Ratios with increased imminent risk for mild cognitive impairment and alzheimer disease. Arch Neurol 64(3):354\u2013362","journal-title":"Arch Neurol"},{"issue":"1","key":"861_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/01.wnl.0000191403.95453.6a","volume":"66","author":"ME Gurol","year":"2006","unstructured":"Gurol ME, Irizarry MC, Smith EE et al (2006) Plasma \u03b2-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66(1):23\u201329","journal-title":"Neurology"},{"issue":"6","key":"861_CR22","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE et al (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain 131(6):1630\u20131645","journal-title":"Brain"},{"issue":"4","key":"861_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, Bernstein MA, Fox NC et al (2008) The Alzheimer\u2019s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685\u2013691","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"861_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9(1):119\u2013128","journal-title":"Lancet Neurol"},{"issue":"3","key":"861_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","volume":"6","author":"WJ Jagust","year":"2010","unstructured":"Jagust WJ, Bandy D, Chen K et al (2010) The Alzheimer\u2019s disease neuroimaging Initiative positron emission tomography core. Alzheimers Dement 6(3):221\u2013229","journal-title":"Alzheimers Dement"},{"key":"861_CR26","volume-title":"Boston naming test","author":"E Kaplan","year":"1983","unstructured":"Kaplan E, Goodglass H, Weintraub S (1983) Boston naming test. Lea & Febiger, Philadelphia"},{"issue":"3","key":"861_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12603-009-0062-5","volume":"13","author":"DR Lachno","year":"2009","unstructured":"Lachno DR, Vanderstichele H, De Groote G et al (2009) The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma beta-amyloid isoforms using the INNO-BIA plasma Abeta forms multiplex assay. J Nutr Health Aging 13(3):220\u2013225","journal-title":"J Nutr Health Aging"},{"issue":"11","key":"861_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1212\/WNL.0b013e3181b78448","volume":"73","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Schraen-Maschke S, Richard F et al (2009) Association of plasma amyloid \u03b2 with risk of dementia. Neurology 73(11):847\u2013853","journal-title":"Neurology"},{"issue":"4","key":"861_CR29","doi-asserted-by":"publisher","first-page":"e18536","DOI":"10.1371\/journal.pone.0018536","volume":"6","author":"JC Lambert","year":"2011","unstructured":"Lambert JC, Dallongeville J, Ellis KA et al (2011) Association of plasma a\u03b2 peptides with blood pressure in the elderly. PLoS ONE 6(4):e18536","journal-title":"PLoS ONE"},{"issue":"4","key":"861_CR30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3233\/JAD-2010-100510","volume":"21","author":"C Laske","year":"2010","unstructured":"Laske C, Sopova K, Gkotsis C et al (2010) Amyloid-\u03b2 peptides in plasma and cognitive decline after 1 year follow-up in alzheimer\u2019s disease patients. J Alzheimers Dis 21(4):1263\u20131269","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"861_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.expneurol.2009.07.024","volume":"223","author":"P Lewczuk","year":"2010","unstructured":"Lewczuk P, Kornhuber J, Vanmechelen E et al (2010) Amyloid beta peptides in plasma in early diagnosis of Alzheimer\u2019s disease: a multicenter study with multiplexing. Exp Neurol 223(2):366\u2013370","journal-title":"Exp Neurol"},{"issue":"6","key":"861_CR32","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archneur.65.6.776","volume":"65","author":"JJ Locascio","year":"2008","unstructured":"Locascio JJ, Fukumoto H, Yap L et al (2008) Plasma amyloid {beta}-protein and c-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol 65(6):776\u2013785","journal-title":"Arch Neurol"},{"issue":"19","key":"861_CR33","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1212\/01.wnl.0000306696.82017.66","volume":"70","author":"OL Lopez","year":"2008","unstructured":"Lopez OL, Kuller LH, Mehta PD et al (2008) Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology 70(19):1664\u20131671","journal-title":"Neurology"},{"issue":"4","key":"861_CR34","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3233\/JAD-2010-090249","volume":"20","author":"JK Lui","year":"2010","unstructured":"Lui JK, Laws SM, Li Q-X et al (2010) Plasma amyloid-\u03b2 as a biomarker in Alzheimer\u2019s disease: the AIBL study of aging. J Alzheimers Dis 20(4):1233\u20131242","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"861_CR35","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP et al (2003) Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents. J Med Chem 46(13):2740\u20132754","journal-title":"J Med Chem"},{"issue":"3","key":"861_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A","volume":"46","author":"R Mayeux","year":"1999","unstructured":"Mayeux R, Tang M-X, Jacobs DM et al (1999) Plasma amyloid \u03b2-peptide 1-42 and incipient Alzheimer\u2019s disease. Ann Neurol 46(3):412\u2013416","journal-title":"Ann Neurol"},{"issue":"9","key":"861_CR37","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","volume":"61","author":"R Mayeux","year":"2003","unstructured":"Mayeux R, Honig LS, Tang M-X et al (2003) Plasma A\u03b240 and A\u03b242 and Alzheimer\u2019s disease: relation to age, mortality, and risk. Neurology 61(9):1185\u20131190","journal-title":"Neurology"},{"issue":"1\u20132","key":"861_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","volume":"304","author":"PD Mehta","year":"2001","unstructured":"Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP (2001) Amyloid [beta] protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 304(1\u20132):102\u2013106","journal-title":"Neurosci Lett"},{"issue":"3","key":"861_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA et al (2010) Alzheimer\u2019s disease neuroimaging initiative (ADNI): clinical characterization. Neurology 74(3):201\u2013209","journal-title":"Neurology"},{"key":"861_CR40","unstructured":"R Development Core Team (2010) R: A language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http:\/\/www.R-project.org\/"},{"key":"861_CR41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"R Reitan","year":"1958","unstructured":"Reitan R (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271\u2013276","journal-title":"Percept Mot Skills"},{"issue":"3","key":"861_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/archneurol.2010.19","volume":"67","author":"DM Rentz","year":"2010","unstructured":"Rentz DM, Locascio JJ, Becker JA et al (2010) Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol 67(3):353\u2013364","journal-title":"Ann Neurol"},{"key":"861_CR43","volume-title":"L\u2019examen clinique en psychologie","author":"A Rey","year":"1964","unstructured":"Rey A (1964) L\u2019examen clinique en psychologie. Presses Universitaires de France, Paris"},{"issue":"11","key":"861_CR44","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"W Rosen","year":"1984","unstructured":"Rosen W, Mohs R, Davis K (1984) A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry 141(11):1356\u20131364","journal-title":"Am J Psychiatry"},{"issue":"1","key":"861_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/13854049208404117","volume":"6","author":"JR Ryan","year":"1992","unstructured":"Ryan JR, Paolo AM (1992) A screening procedure for estimating premorbid intelligence in the elderly. Clin Neuropsychol 6(1):53\u201362","journal-title":"Clin Neuropsychol"},{"issue":"37","key":"861_CR46","doi-asserted-by":"publisher","first-page":"14052","DOI":"10.1073\/pnas.0805902105","volume":"105","author":"N Schupf","year":"2008","unstructured":"Schupf N, Tang MX, Fukuyama H et al (2008) Peripheral A\u03b2 subspecies as risk biomarkers of Alzheimer\u2019s disease. Proc Nat Acad Sci 105(37):14052\u201314057","journal-title":"Proc Nat Acad Sci"},{"issue":"18","key":"861_CR47","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/WNL.0b013e3181fb448b","volume":"75","author":"N Schupf","year":"2010","unstructured":"Schupf N, Zigman WB, Tang M-X et al (2010) Change in plasma A\u03b2 peptides and onset of dementia in adults with Down syndrome. Neurology 75(18):1639\u20131644","journal-title":"Neurology"},{"issue":"10","key":"861_CR48","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/jnnp.2010.205757","volume":"81","author":"TT Sepp\u00e4l\u00e4","year":"2010","unstructured":"Sepp\u00e4l\u00e4 TT, Herukka S-K, H\u00e4nninen T et al (2010) Plasma A\u03b242 and A\u03b240 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. J Neurol Neurosurg Psychiatry 81(10):1123\u20131127","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"861_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M et al (2009) Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol 65(4):403\u2013413","journal-title":"Ann Neurol"},{"issue":"5","key":"861_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","volume":"121","author":"LM Shaw","year":"2011","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M et al (2011) Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol 121(5):597\u2013609","journal-title":"Acta Neuropathol"},{"key":"861_CR51","unstructured":"Song F, Poljak A, Valenzuela M, et al (2011) Meta-Analysis of Plasma Amyloid-beta levels in Alzheimer\u2019s Disease. J Alzheimers Dis (1875-8908 (Electronic))"},{"issue":"2","key":"861_CR52","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/archneurol.2007.57","volume":"65","author":"J Sundelof","year":"2008","unstructured":"Sundelof J, Giedraitis V, Irizarry MC et al (2008) Plasma beta amyloid and the risk of alzheimer disease and dementia in elderly men: a prospective, population-based cohort study. Arch Neurol 65(2):256\u2013263","journal-title":"Arch Neurol"},{"issue":"6","key":"861_CR53","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/01688639608408309","volume":"18","author":"K Taylor","year":"1996","unstructured":"Taylor K, Salmon D, Rice V et al (1996) Longitudinal examination of american national adult reading test (AMNART) performance in dementia of the Alzheimer type (DAT): validation and correction based on degree of cognitive decline. J Clin Exp Neuropsychol 18(6):883\u2013891","journal-title":"J Clin Exp Neuropsychol"},{"issue":"4","key":"861_CR54","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.20050","volume":"55","author":"EJ Dijk Van","year":"2004","unstructured":"Van Dijk EJ, Prins ND, Vermeer SE et al (2004) Plasma amyloid \u03b2, apolipoprotein E, lacunar infarcts, and white matter lesions. Ann Neurol 55(4):570\u2013575","journal-title":"Ann Neurol"},{"issue":"8","key":"861_CR55","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","volume":"5","author":"M Oijen van","year":"2006","unstructured":"van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM (2006) Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5(8):655\u2013660","journal-title":"Lancet Neurol"},{"key":"861_CR56","unstructured":"Wechsler D (1987) Wechsler Memory Scale. Rev ed. Psychological Corp, San Antonio"},{"issue":"2","key":"861_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jalz.2010.08.230","volume":"7","author":"SD Weigand","year":"2011","unstructured":"Weigand SD, Vemuri P, Wiste HJ et al (2011) Transforming cerebrospinal fluid Abeta42 measures into calculated Pittsburgh compound B units of brain Abeta amyloid. Alzheimers Dement 7(2):133\u2013141","journal-title":"Alzheimers Dement"},{"key":"861_CR58","unstructured":"Wilcox RR, Sch\u00f6nbrodt FD (2009) The WRS package for robust statistics in R (version 0.12.1). http:\/\/r-forge.r-project.org\/projects\/wrs\/"},{"issue":"3","key":"861_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2010.1995","volume":"305","author":"K Yaffe","year":"2011","unstructured":"Yaffe K, Weston A, Graff-Radford NR et al (2011) Association of plasma \u03b2-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 305(3):261\u2013266","journal-title":"JAMA"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-011-0861-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-011-0861-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-011-0861-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-011-0861-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:54:20Z","timestamp":1686214460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-011-0861-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,30]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1007\/s00401-011-0861-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13558957.14941057","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,30]]},"article-number":"401"}}